2-Aryloxymethylmorpholine histamine H(3) antagonists.

Bioorg Med Chem Lett

Johnson & Johnson Pharmaceutical Research & Development L.L.C., San Diego, CA 92121-1126, USA.

Published: November 2008

The synthesis and biological activity of a new series of 2-aryloxymethylmorpholine histamine H(3) antagonists is described. The new compounds are high affinity histamine H(3) ligands that penetrate the CNS and occupy the histamine H(3) receptor in rat brain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2008.09.077DOI Listing

Publication Analysis

Top Keywords

2-aryloxymethylmorpholine histamine
8
histamine antagonists
8
antagonists synthesis
4
synthesis biological
4
biological activity
4
activity series
4
series 2-aryloxymethylmorpholine
4
antagonists described
4
described compounds
4
compounds high
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!